College of Maryland, Baltimore (UMB) President Bruce E. Jarrell, MD, FACS, introduced on Jan. 24 that Natalie D. Eddington, PhD, FAAPS, FCP, has determined to step down as dean of the College of Maryland Faculty of Pharmacy (UMSOP) on the finish of this tutorial yr. She is going to stay on school and can lead UMB’s EMBRACE initiative, a multifaceted method designed to extend the vibrancy of the larger UMB campus, enhance UMB’s neighborhood impression in West Baltimore, and strengthen UMB’s profile with our inner and exterior constituencies.
“Dean Eddington’s lengthy and impactful tenure at UMB has been characterised by constructing and main sturdy groups, strategic and entrepreneurial considering, competent and results-oriented management, and establishing and sustaining sturdy and significant relationships. On account of her management, the Faculty of Pharmacy is positioned for continued success,” Jarrell stated in his announcement. “These attributes will probably be important in giving form to the necessary new UMB EMBRACE initiative that she is going to lead.”
An alumna of the varsity, Eddington has served as dean since 2007, having beforehand served UMSOP as an assistant professor, chair of the Division of Pharmaceutical Sciences, and director of the Pharmacokinetics-Biopharmaceutics Laboratory.
A nationally recognized professional in drug supply and pharmacokinetics, Eddington focuses her analysis on drugs used within the therapy of most cancers, epilepsy, arthritis, and medicines of abuse, and on understanding the position of biopharmaceutics and pharmacokinetics in elucidating the underlying mechanisms necessary in optimizing drug remedy. Her analysis has served as the idea for quite a few regulatory guidances applied by the Meals and Drug Administration (FDA).
Underneath her management, UMSOP has established a number of facilities and applications together with the Middle for Modern Pharmacy Options; the Sufferers, Pharmacists, Partnerships Program; the PATIENTS Program; the Bio- and Nano-Know-how Middle; the Middle for Translational Medication; the Mass Spectrometry Middle; the Metallotherapeutics Analysis Middle, and the Maryland Middle of Excellence in Regulatory Science and Innovation. As well as, Eddington has designed quite a few worldwide regulatory programs for clinicians and scientists from South Korea, Argentina, Brazil, the US, and Japan on the US’ drug growth course of and the FDA regulatory infrastructure surrounding medicine and machine growth. Most not too long ago, underneath her management, UMSOP launched a transformational Pharmapreneurship initiative.
Throughout her tenure, Eddington oversaw the enlargement of the Faculty of Pharmacy’s bodily footprint with the opening of Pharmacy Corridor Addition in 2010, a 126,000 sq. foot, seven-story constructing that offered trendy studying, working, analysis, and collaboration areas for school, employees, and college students. She additionally oversaw the enlargement of the Faculty’s tutorial choices, which now embody the Physician of Pharmacy program, three PhD applications, and 6 MS applications, together with the primary of its type MS in Medical Hashish Science and Therapeutics.
“Nearly all of my skilled life has been spent on the College of Maryland Faculty of Pharmacy, an establishment that I like,” Eddington stated. “It’s right here that I’ve realized, grown, and served an distinctive neighborhood of scholars, school, employees, preceptors, alumni, and collaborators. It has been the respect of my profession to serve for the final 15 years as dean and to have had a entrance row seat to witness the experience, affect, and impression of our students, practitioners, researchers, and professionals.”
A nationwide seek for a brand new UMSOP dean will probably be performed.